J&J posts 1 percent profit rise despite sales drop

The maker of Band-Aids, biotech drugs and Acuvue contact lenses says it earned $3.35 billion in the quarter, or $1.20 per share. In last year's third quarter, it had net income of $3.31 billion, or $1.17 per share.

Analysts polled by Thomson Financial were expecting lower earnings per share, at $1.13, and revenue of $15.19 billion in the latest quarter.

J&J just missed the revenue forecast, reporting total sales of $15.08 billion. That's down 5 percent from a year ago.

• Save money with Local Coupons
• Coupon Bug helps you save cash
• Saving with 6abc reports
• Share on the Saving with 6abc Message Board
• Track your stocks
• Follow Action News on Twitter
• Get Action News on your website
• Follow Action News on Facebook
• The latest Philadelphia headlines from the Delaware and Lehigh valleys